Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(1.78)
# 1,152
Out of 5,182 analysts
25
Total ratings
34.78%
Success rate
-5.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Atrium Therapeutics | Suspends: Neutral | n/a | $13.07 | - | 3 | May 1, 2026 | |
| MAZE Maze Therapeutics | Maintains: Buy | $60 → $110 | $26.03 | +322.59% | 5 | Mar 25, 2026 | |
| GPCR Structure Therapeutics | Maintains: Buy | $114 → $100 | $39.10 | +155.75% | 4 | Mar 16, 2026 | |
| DYN Dyne Therapeutics | Maintains: Buy | $60 → $50 | $17.61 | +183.93% | 3 | Mar 3, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $37 | $22.40 | +65.18% | 2 | Feb 3, 2026 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $50 | $32.89 | +52.02% | 1 | Dec 15, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $1.76 | +1,036.36% | 3 | Nov 13, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $5.37 | +346.93% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $0.86 | +2,218.30% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $5.69 | +146.05% | 1 | Aug 15, 2025 |
Atrium Therapeutics
May 1, 2026
Suspends: Neutral
Price Target: n/a
Current: $13.07
Upside: -
Maze Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $60 → $110
Current: $26.03
Upside: +322.59%
Structure Therapeutics
Mar 16, 2026
Maintains: Buy
Price Target: $114 → $100
Current: $39.10
Upside: +155.75%
Dyne Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $60 → $50
Current: $17.61
Upside: +183.93%
ACADIA Pharmaceuticals
Feb 3, 2026
Reiterates: Buy
Price Target: $37
Current: $22.40
Upside: +65.18%
Stoke Therapeutics
Dec 15, 2025
Maintains: Buy
Price Target: $35 → $50
Current: $32.89
Upside: +52.02%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $1.76
Upside: +1,036.36%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $5.37
Upside: +346.93%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $0.86
Upside: +2,218.30%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $5.69
Upside: +146.05%